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Abstract: Preservation of neuronal tissue is crucial for recovery after stroke, but studies suggest that
prolonged neuronal loss occurs following acute ischaemia. This study assessed the temporal pattern
of neuronal loss in subacute ischemic stroke patients using 1H magnetic resonance spectroscopy,
in parallel with functional recovery at 2, 6 and 12 weeks after stroke. Specifically, we measured
N-acetylaspartate (NAA), choline, myoinositol, creatine and lactate concentrations in the ipsilesional
and contralesional thalamus of 15 first-ever acute ischaemic stroke patients and 15 control participants
and correlated MRS concentrations with motor recovery, measured at 12 weeks using the Fugl–Meyer
scale. NAA in the ipsilesional thalamus fell significantly between 2 and 12 weeks (10.0 to 7.97 mmol/L,
p = 0.003), while choline, myoinositol and lactate concentrations increased (p = 0.025, p = 0.031,
p = 0.001, respectively). Higher NAA concentrations in the ipsilesional thalamus at 2 and 12 weeks
correlated with higher Fugl Meyer scores at 12 weeks (p= 0.004 and p= 0.006, respectively). While these
results should be considered preliminary given the modest sample size, the progressive fall in NAA
and late increases in choline, myoinositol and lactate may indicate progressive non-ischaemic neuronal
loss, metabolically depressed neurons and/or diaschisis effects, which have a detrimental effect on
motor recovery. Interventions that can potentially limit this ongoing subacute tissue damage may
improve stroke recovery.
Keywords: ischaemic stroke; subacute; inflammation; recovery; N-acetylaspartate (NAA),
MR spectroscopy
1. Introduction
Stroke remains the leading cause of acquired adult disability, with up to 30% of survivors suffering
from permanent disability [1]. Preservation of neuronal tissue after injury is key to recovery and is
dependent upon several processes in the post-infarction phase, including further ischaemic damage,
reperfusion, inflammation, gliosis and neuronal repair [2,3]. These processes take place not only in the
core of the infarct but also in structurally and functionally connected areas, remote from the infarct site.
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Neuroimaging methods like Magnetic Resonance (MR) imaging may facilitate the investigation of
these processes and their relationship to functional recovery [4]. Previous diffusion and spectroscopic
magnetic resonance imaging studies have demonstrated progressive neuronal loss in the ipsilesional
thalamus of patients with middle cerebral artery infarction up to 90 days after stroke [5–7], while PET
studies have shown late microglial and tissue macrophage activation in intact regions connected to the
core infarct that can destroy tissue and hamper recovery [8].
In addition, many cellular elements involved in these processes have distinctive chemical
signatures, which can be measured with Proton Magnetic Resonance Spectroscopy (1H-MRS) [9,10].
Specifically, 1H-MRS is sensitive to changes in a number of neuro-metabolites, including
N-acetylaspartate (NAA), which is synthesised exclusively in mitochondria of normal neurons
and which has been related to the proportion or patency of normal neurons [11]. Additional
neuro-metabolites detectable with 1H-MRS include Choline (Cho) containing compounds, which are
involved in membrane synthesis and degradation and are elevated in high turnover states [10],
and myoinositol (mI), predominantly reflecting increased glial activity [10]. A rapid rise in lactate
indicates a switch from oxidative metabolism to anaerobic glycolysis with ischaemia, but a sustained
low rise has been attributed to anaerobic glycolysis in activated macrophages [12]. Creatine (Cr) is
a marker for energy metabolism and reflects the balance between energy demand and supply [10].
In addition, these post-infarct processes are associated with changes in perfusion [13], which can be
reliably measured using Arterial Spin Labelling (ASL) in acute stroke patients [14].
Previous studies of NAA after stroke confirm an acute decrease in NAA in the centre of ischemic
lesions consistent with neuronal loss [6,15]. Although much of the total tissue damage occurs in the
first few hours after stroke, there is evidence that damage may continue subacutely from secondary
factors [7,8]. There are also ongoing processes of repair; animal studies demonstrate neurogenesis in
the periventricular subependymal regions with neuron migration towards damaged areas, which may
increase neuron density [3]. The duration of further damage or repair, the factors that influence these
processes, and their relationship to functional recovery remain unclear but may offer potential targets
for therapeutic interventions.
The aim of this study was to investigate the time course of subacute neuronal loss in a structurally
undamaged region connected to, but not included in, the infarct using 1H-MRS signals as markers of
cellular changes. The relationship between perfusion (quantified with arterial spin labelling), neuronal
density as measured by NAA concentrations at 2 and 12 weeks and functional recovery at 12 weeks
was also assessed, in order to test the hypothesis that MRI and MRS markers of cellular changes may
represent predictors for functional outcome after stroke.
2. Materials and Methods
2.1. Subjects
The study included 23 right-handed patients aged 18–75 years with moderate to severe cortical
ischemic stroke recruited within 2 weeks of stroke onset and 15 age and sex matched controls. Inclusion
criteria were first-ever ischaemic strokes on MR imaging, cortical lesion in the middle cerebral artery
territory area with thalamic sparing (Figure 1), National Institutes of Health Stroke Scale (NIHSS)
Score 2–3 for motor arm and leg, and capacity to consent and participate with imaging and clinical
assessments. Patients with significant (≥50%) carotid or intracranial artery stenosis, age-related white
matter changes (ARWMC) score ≥2 in the white matter or basal ganglia [16] or contraindications to
MR imaging were excluded. Age and sex matched controls with no evidence of silent infarction on
MR imaging or other exclusion criteria (e.g., contraindications for MRI) were recruited by invitation
from the community. Stroke patients received inpatient or outpatient rehabilitation therapy as part of
routine care. Informed consent was obtained, and the study was approved by the London South East
Research Ethics Committee (09/H0803/149).






Figure 1. T2 weighted lesion overlay maps of 15 stroke patients at baseline (a) and 12 weeks (b).
For patients with right-sided strokes, images were flipped before delineating the lesions.
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2.2. Imaging Techniques
MR imaging studies were performed with a 3.0 Tesla General Electric HDx MRI scanner
(GE Medical Systems, Milwaukee, WI, USA), using an 8-channel head coil. The imaging protocol
lasted about 60 min and consisted of T1 and T2 weighted structural imaging (15 min), Diffusion Tensor
Imaging (15 min), MRS (20 min) and ASL (5 min).
Structural imaging for anatomical localisation and assessment of volume of infarction
was performed using T2-weighted and fluid attenuation inversion recovery (FLAIR) sequences,
prescribed parallel to the AC/PC line. T2-weighted scans had echo time (TE) = 103 ms, repetition time
(TR) = 3520 ms, 19 slices (5 mm/2 mm gap); FLAIR scans had inversion time (TI) = 2000 ms, echo time
(TE) = 128 ms, repetition time (TR) = 2000 ms, 36 slices (4mm/4mm gap). Parallel imaging (ASSET,
with a speed up factor of 2) was used to allow greater slice coverage per unit time. Lesion overlap
maps were generated after manually outlining the lesions on the T2-weighted images for each patient
in mricron (http://neuro.debian.net/pkgs/mricron.html).
The MRS volume of interest (VOI) was centred on the ipsilesional thalamus leaving a clear margin
with affected areas (Figure 2). The thalamus is a fixed landmark between the sub-ependymal zone and
infarcted tissue, where post-ischaemic cellular/metabolic events have been described in experimental
models [3]. In addition, it is a major relay for centrifugal cortical pathways, known to show neuronal
loss and inflammation after stroke [5,7,8]. The contralesional thalamus was also studied because of
evidence of activation during recovery in functional imaging studies [17].
 
Figure 2. (a) Volume of Interest (VOI) for 1H-MRS, (b) representative MRS spectra acquired from a
stroke patient at baseline and 12 weeks, (c) Scatter plot depicting the Fugl–Meyer score at 12 weeks vs.
ipsilesional (thalamic) N-acetylaspartate (NAA) at 2 weeks.
MRS studies were localised using a 3D fast inversion-recovery prepared spoiled gradient
acquisition in the steady state (IR-SPGR) scan, with TI = 450 ms, TE = 3 ms and TR = 7 ms.
The volumetric IR-SPGR images were segmented into grey matter, white matter and CSF maps using
SPM (www.fil.ion.ucl.ac.uk/spm). Single voxel 1HMR spectra were acquired from thalamic voxels
of interest (VOI, size: 20 × 15 × 20 mm3), using a point resolved spectroscopy (PRESS) sequence
with TE = 30 ms and TR = 3 s. Water-scaled metabolite concentrations were derived with LC Model
(Figure 2) [18]. Estimated concentrations with a Cramer Rao Lower Bound (%CRLB) of greater than 20%
for NAA, Cr, Cho and mI, or greater than 40% for Lactate were excluded from further statistical analyses.
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The in vivo water-scaled concentrations reported by LC Model were divided by the SPM-derived
fractional content of brain tissue (p[GM] + p[WM], where p[GM] and p[WM] represent the percentage
of grey matter and white matter in the voxel, respectively) to correct for partial volume contamination
of cerebrospinal fluid (CSF) in the 1H-MRS voxel. The water concentration used for water scaling was
also corrected for the amount of CSF in the 1H-MRS voxel, assuming a CSF water concentration of
55.556 M.
Whole-brain resting cerebral perfusion images were collected with a background-suppressed,
pulsed continuous arterial spin labelling (pCASL) sequence, using a 3D stack of spirals fast
spin echo readout [19]. Sixty axial slices were collected, with TR = 5.5 s, TE = 25 ms,
acquisition matrix = 64 × 64 pixels, slice thickness = 3 mm, field of view = 24 cm, and reconstruction




Figure 3. Representative Arterial Spin Labelling (ASL) dataset from a stroke patient at 2 weeks (a) and
12 weeks (b). A large area of reduced perfusion is seen at 12 weeks within the area affected by the
stroke (solid arrows), but some regions within the affected area show a mild recovery of perfusion at
12 weeks (dashed arrows).
Baseline scanning was performed at 2 weeks post-stroke to reduce confounds from vascular
or chemical changes from impaired autoregulation, acute ischemic cascade, hypoxic lactate surge
and cerebral oedema. Follow-up assessments were undertaken at 6 ± 1 and 12 ± 3 weeks after
stroke, the time-points associated with greatest functional recovery in stroke rehabilitation studies [17].
The patient’s head position during the initial scan was recorded and replicated on follow-up scans.
The spectroscopy VOI was carefully placed in the same position relative to the lesion and relevant
anatomical landmarks on each occasion.
2.3. Clinical Assessments
Baseline assessment at 2 weeks included age, sex, vascular risk profile, medication and NIHSS
score. Motor impairment was assessed using the Fugl–Meyer scale [20] and repeated at 6 and 12 weeks.
Overall function was measured using the Functional Independence Measure (FIM) at the same time
points [21]. Motor assessments were performed by trained therapists following a standardised protocol.
Clinical assessments were undertaken on the same day as MR imaging, but investigators undertaking
image analysis were blinded to the findings of the clinical assessments.
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2.4. Data Analysis
For each patient, we calculated values of CBF, NAA, Cho, mI, Cr and lactate for each VOI.
Data from ipsi- and contra-lateral thalamus for all patients and controls were normally distributed
(Kolmogorov–Smirnov tests). Differences in CBF and metabolites between patients and controls were
assessed by independent sample t tests.
Within-subject differences in CBF and metabolites between baseline, 6 and 12 weeks were assessed
using ANCOVA for repeated measures adjusted for age, baseline NIHSS score and lesion volume,
using predictive model-based imputation for missing data points (5 in 120 assessments). This method
can assess within-subject differences whilst allowing for between subject variations and reduces bias
due to only including patients in whom all data for the 3 time points is available [22].
Spearman rank order correlation was used to evaluate hypothesis driven relationships between
NAA, CBF and Fugl–Meyer score at 12 weeks. In order to minimise false positive results because of
multiple testing, correlations were only performed if NAA concentration or CBF was significantly
different from controls at baseline or showed a significant temporal trend. Differences were considered
significant at the two-sided p value of p ≤ 0.05.
3. Results
3.1. Patient Characteristics
Of the 23 stroke patients recruited at baseline, 4 declined further imaging, and 4 were withdrawn
because of poor image quality. The mean age of the remaining 15 patients (9 men) was 51.4 ± 13.3 years
(Range 21–75), and their median National Institutes of Health Stroke Scale (NIHSS) score was
9 (IQR 3–15) at 2 weeks. Of these, 3 had a total anterior circulation stroke syndrome, and 12 had a
partial anterior circulation stroke syndrome (Figure 1). Vascular risk factors in stroke patients included
hypertension (5/15), type II diabetes mellitus (3/15), hypercholesterolaemia (8/15) and smoking (4/15).
The mean age of healthy controls (10 men) was 49.1± 9.3 years. Vascular risk factors in controls included
hypertension (6/15), type II diabetes mellitus (1/15), hypercholesterolaemia (4/15) and smoking (4/15).
3.2. Temporal Evolution of NAA and Other Metabolites
Twelve of the fifteen infarcts were in the left hemisphere, and the median stroke lesion volume
at 2 weeks was 20.4 (IQR 6.7–37.4) cm3. The median infarct volume was 11.6 (IQR 7.1–23.0) cm3 at
12 weeks.
Metabolite concentrations from MRS voxels positioned in the ipsilesional and contralesional
thalamus are given in Table 1, together with the statistical results from both the repeated-measures
ANCOVA assessing longitudinal changes in the patient group, and the two-sample t-test assessing
groupwise differences between the controls and the patients at baseline.
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Table 1. Longitudinal changes in the mean concentration of metabolites (measured as mmol/L)
and regional perfusion in the intact ipsilesional and contralesional thalamus between 2 and
12 weeks post-stroke.












10.0 (2.03) 6.85 (4.08) 7.97 (1.69) 0.003 **
Contralesional
thalamus
10.46 (1.94) 12.18 (3.42) 10.52 (0.92) 0.19
Control Left thalamus 11.17 (1.01) 0.27
Right thalamus 11.19 (0.59) 0.23
Cho
(mmol/L)
Patient Ipsilesional 2.33 (0.35) 2.51 (1.17) 2.82 (0.58) 0.025 *
Contralesional 1.98 (0.28) 2.40 (0.90) 2.56 (1.18) 0.22
Control left 2.06 (0.33) 0.009 **
right 2.00 (0.21) 0.87
mI
(mmol/L)
Patient Ipsilesional 4.29 (2.06) 4.07 (3.11) 6.33 (3.21) 0.031 *
Contralesional 4.38 (2.25) 4.29 (1.54) 4.32 (1.43) 0.82
Control left 4.07 (1.44) 0.62
right 3.97 (1.06) 0.27
Creatinine
(mmol/L)
Patient Ipsilesional 5.63 (0.36) 6.31 (1.33) 7.38 (1.75) 0.003 **
Contralesional 6.63 (2.19) 6.86 (2.82) 6.14 (3.20) 0.44
Control left 7.08 (0.66) 0.0001 *
right 6.92 (2.14) 0.43
Lactate
(mmol/L)
Patient Ipsilesional 0.90 (1.11) 1.77 (1.61) 2.03 (1.49) 0.001 **
Contralesional 0.66 (1.13) 0.70 (1.16) 0.72 (0.67) 0.79
Control left 0.47 (0.70) 0.27




Patient Ipsilesional 22.72 (8.18) 31.84 (4.75) 31.04 (4.18) 0.004 **
Contralesional 32.93 (8.47) 36.10 (4.82) 32.17 (8.32) 0.58
Control left 36.81 (6.77) 0.004 **
right 38.64 (7.95) 0.25
Clinical assessments (patients only) Baseline 6 weeks 12 weeks p-value (longitudinal change in patients)
Fugl–Meyer 43.3 (30.0) 74.2 (32.2) 78.3 (30.1) 0.009 **
§ For the comparison of concentrations between patients (at baseline) and controls, the baseline ipsilesional thalamic
concentrations in patients were compared with left thalamic concentrations in controls * p < 0.05, ** p < 0.01.
The NAA concentration in the structurally intact ipsilesional thalamus was comparable to that
measured in the healthy controls at 2 weeks. There was a significant decrease thereafter, reaching a
nadir at 6 weeks followed by a small increase by 12 weeks (Table 1). The repeated measures ANCOVA
model showed that NAA concentration was significantly reduced between 2 and 12 weeks (p = 0.003,
Table 1). These results remained significant after removal of the patient with the largest lesion volume.
Choline concentration in the intact ipsilesional thalamus, indicative of high membrane turnover,
was significantly higher than in controls at 2 weeks (p = 0.009, Table 1) and continued to rise between
2–12 weeks (p = 0.025). Myoinisitol concentration, a measure of glial activity, was comparable with
controls at 2 weeks but increased significantly between 2–12 weeks (p = 0.031).
Thalamic lactate concentration was comparable with controls at baseline but increased significantly
by 12 weeks. The concentration of creatinine, a marker for energy homeostasis, was significantly
lower in the ipsilesional thalamus compared with healthy controls at 2 weeks (Table 1) but increased
significantly between 2 and 12 weeks (p = 0.003)
NAA, Cho, mI, Lac and Cr concentrations in the contralesional thalamus were comparable with
healthy controls at 2 weeks, and there were no significant changes in their concentrations between 2
and 12 weeks.
3.3. Temporal Evolution of CBF
Ipsilesional thalamic perfusion was lower compared with healthy controls and also to the
contralesional thalamus at 2 weeks (Table 1) but increased significantly between 2 and 12 weeks
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(p = 0.004), while still remaining below control values. CBF in the contralesional thalamus was
comparable to that in the healthy controls at 2 weeks and showed no significant temporal changes.
3.4. Relationship of MRS and ASL Measures with Outcome
Stroke patients showed significant clinical improvements in neurological deficits and motor
impairments between 2 and 12 weeks. The mean Fugl–Meyer motor score improved from 43.3 ± 30.0
(SD) at 2 weeks to 78.3 ± 30.1 (p = 0.009) at 12 weeks (score range 0–100, worst to best), and their FIM
score, a measure of functional ability, improved from 65 ± 19 to 89 ± 5 (p = 0.003, score range 18–126,
worst to best).
Higher NAA concentration in the ipsilesional thalamus at 2 and 12 weeks correlated with a
higher Fugl–Meyer score at 12 weeks (Spearman’s rho = 0.79, p = 0.004 and rho = 0.80, p = 0.006,
respectively). Higher choline concentration at 12 weeks correlated with lower Fugl–Meyer scores at
12 weeks (rho = −0.756, p = 0.018).
Higher CBF in the ipsilesional thalamus at 2 weeks correlated with higher NAA concentration at
12 weeks (r2 = 0.42, p = 0.002) and higher Fugl–Meyer score at 12 weeks (r2 = 0.817, p = 0.001).
4. Discussion
The longitudinal changes observed in NAA and CBF between 2 and 12 weeks after stroke provide
an insight into subacute neuronal loss after ischaemic stroke and its relationship to recovery. They show
that in the ipsilesional, structurally intact thalamus there is further neuronal loss (NAA reduction) after
2 weeks of acute injury, which reaches maximum at approximately 6 weeks, followed by a rebound at
12 weeks to values lower than at baseline. They also demonstrate a relationship between surviving and
functioning neurons (NAA concentration) and extent of motor recovery following stroke, such that
higher ipsilesional thalamic NAA levels seem to be linked to a better clinical recovery. Conversely,
elevated Choline levels were predictive of a worse clinical recovery, while there was a suggestion that
higher regional perfusion may be important in limiting neuronal loss and promoting motor recovery.
A possible explanation for the decrease in NAA concentrations at 6 weeks and a rebound at
12 weeks could be experimental bias due to changes in head or voxel positioning, scanner drift,
partial volume averaging, changes in metabolite relaxation times or tissue oedema. Extreme care
was taken to match position of voxels on all scans and standardise imaging protocols. Changes
in NAA concentration are unlikely to be due to dilution effects of residual tissue oedema because
the voxels were placed in a region outside the infarct zone, and baseline imaging was performed at
2 weeks, by which time tissue oedema would be resolved [23]. That the changes in NAA concentrations
genuinely represent a loss of density or function of neurons is supported by increases in choline and
myoinositol concentrations, suggestive of increased membrane turnover and gliosis [10] and a lack of
similar changes in the contralesional thalamus, where metabolite concentrations remained comparable
with controls. It is also unlikely that this decrease in NAA is due to acute ischaemia because the
lactate concentrations at two weeks, which would reflect underlying anaerobic glycolysis, were not
elevated and were comparable with those in the contralesional thalamus and with healthy controls.
The presence of lactate in healthy controls was unexpected, but studies have shown small lactate
signals in healthy people, which are considered intrinsic to ageing [24].
Ischemic neuronal damage occurs within the first few hours of stroke. The substantial reductions
in NAA beyond 12–14 days and in areas remote from infarction seen in this and other studies [5–7]
suggest a loss of neurons (or reduction in neuronal function) beyond the acute ischaemic phase.
However, it is quite possible that a wider zone of subacute ischaemia may exist beyond acute injury,
and diaschisis may also provide an alternative explanation for the progressive decrease in NAA.
In comparison to a previous serial MR spectroscopy study in stroke patients [6], NAA levels reached a
nadir slightly later than previously reported (namely at 6 weeks in the present study, rather than at
2 weeks, as reported previously) [6]. However, the nadir of 2 weeks was reported for voxels classified
as “possibly or definitely abnormal” based on imaging findings, suggesting that neuronal loss may
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take place more quickly in the infarct zone than in areas remote from the infarct. Perfusion of the
ipsilesional thalamus at baseline was also reduced compared with the contralesional thalamus and
controls. While this reduction to 22.7 mL/100 g/min is not severe enough to lead to neuronal death [14],
since the perfusion was averaged over the thalamus, there may be areas with this region demonstrating
perfusion below the ischemic threshold.
One possible explanation for the apparent loss of neuronal density and/or function may be
inflammation due to microglial activation. This is supported by the small rise in lactate indicative
of infiltration with macrophages (high rate of anaerobic glycolysis) [12] and increased myoinositol
and creatine concentrations suggestive of microglial activation (glial cells have 2–4 times more
myoinositol and creatine than neurons [10]. The shared cellular lineage and reaction profiles of
microglia and tissue macrophages suggest a neuroinflammatory reaction rather than recruitment of
blood-borne cells. Inflammation and neuronal loss have also been reported in previous studies [8,25].
Stroke patients followed up for 150 days showed a late and prolonged microglial response in
intact but structurally connected areas, which was dominated by tissue phagocytes and tissue
destruction [8]. More recently, experimental stroke studies have shown inflammation 4–8 weeks
after lesion induction [25]. Tissue infiltrated with phagocytes showed severe injury and necrosis,
whereas tissue with non-phagocytic inflammation remained viable and remodelled after weeks.
Non-phagocytic inflammation with remodelling may explain the rebound in NAA seen in this study.
Reductions in NAA, which later recover, have also been observed in animal models of multiple sclerosis
and attributed to tissue fluid changes secondary to inflammation [26,27].
However, an alternative explanation for the reduction in NAA over time may be diaschisis due to
loss of input from infarcted regions. Diaschisis may also underly the apparent reduction in thalamic
perfusion, as reduced perfusion due to diaschisis in stroke patients has previously been observed
with ASL [28]. Diaschisis has also been reported to underly changes in NAA levels in stroke patients,
and recovery of diaschitic tissue has been implicated as an important factor governing functional
recovery [29,30].
A relationship between higher ispilesional NAA concentrations in the peri-infarct zone and greater
extent of motor recovery has previously been shown in stroke patients studied more than 6 months
after stroke [31]. This study extends these findings to intact ipsilesional regions connected to the core
infarct in the subacute phase of stroke. It suggests that neuronal degeneration, possibly related to
diaschisis or inflammation along the neuronal pathways expected to develop Wallerian degeneration,
has a detrimental effect on motor recovery. It also showed that higher ipsilesional perfusion was
associated with a significantly lower fall in NAA concentrations between 2 and 12 weeks and higher
concentrations of NAA and better motor recovery at 12 weeks. Increased perfusion after stroke has
been related to higher NAA concentrations in damaged areas in other studies and has been suggested
to be a substrate for recovery [32], but this relationship and the mechanisms underlying it need
further exploration.
The strengths of the present study are three fixed and conceptually valid time points for assessment
of recovery [17], the evaluation of relevant clinical outcome measures as well as spectroscopic markers,
inclusion of all patient data (not just those scanned at all times) by using predictive model-based
imputation, extreme care to match position of voxels on all scans, image analysis techniques that
minimised bias due to tissue compartments, lesion anatomy or volume loss and standardised
measurement of metabolite values. Most previous studies have used either single modality or focused
on single metabolites, but few have combined multimodality and multimetabolite measurements in a
single investigation. In addition, there are very few spectroscopic studies of changes in spared but
functionally connected ipsilesional structures during the phase of greatest motor recovery in stroke
patients. As far as we are aware, the present study is the first to link multimodality measurements to
clinical outcome measures, enabling the relevance of MRS and MRI measures as predictors of clinical
recovery to be assessed.
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A major limitation of this investigation is the modest sample size, and corresponding susceptibility
to inadvertent bias because of multiple comparisons in a small number of patients. To reduce
heterogeneity and potential sources of bias we have used restrictive inclusion criteria, standardised
protocols for imaging and performed hypothesis driven analyses. We were unable acquire all data as
planned (4/23 withdrew and 4/23 were excluded due to poor data quality, 5 in 120 assessments were
not performed) or adjust fully for regional tissue distortion on follow-up scans due to changes in mass
effect of the infarct. This effect is likely to be minimal, as patients were included after any oedema
would have resolved, and voxels were placed in structurally intact tissue, with a clear margin from the
infarct. While the timing of the baseline measurement was selected to avoid confounds from oedema,
measurements at an earlier time point would provide additional information, and caution needs to
be exercised in extrapolating metabolite findings to underlying histological changes. The metabolic
findings of this study are consistent with other longitudinal stroke studies [5,6], histopathology
correlates of spectral changes in stroke patients [12] and metabolic profiles of various cell types in
in-vitro studies [9,10].
5. Conclusions
To conclude, this study provides preliminary spectroscopic evidence of progressive neuronal
degeneration in the intact ipsilesional thalamus during the subacute phase of stroke, which correlated
inversely with the extent of recovery. Possible mechanisms for post-ischaemic degenerative changes
include diaschisis or inflammation along neuronal pathways connected to the core infarct, raising the
possibility of targeting this mechanism as a potential therapeutic intervention to improve recovery
from stroke.
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